banner
Enzymatic Release

Enzymatic Release

Studying the detailed structural and functional characterization of different types of glycans is essential to understand the mechanism of various biological activities and the pathology of several diseases. CD BioGlyco has been trying to develop simple and effective enzymatic methods to release glycans from complex biological samples. We expect to be your research assistant in the field of glycobiology.

Unlock Glycans: Enzymatic Release for Deeper Insights

Enzymatic Release

Glycosylation is an important way of post-translational modification of proteins, which has a variety of biological functions, such as immune recognition, signal transduction, cell adhesion, and tumorigenesis. Therefore, the development of effective methods to release glycans from the protein backbone is of great significance to the study of their structure and function.

In contrast to chemical methods of glycan release, enzymatic release can be carried out with minimum instructions in any laboratory. In the past two decades, more and more enzymes including endoglycosidases and glycosidases have been reported to release glycans from glycoproteins under mild conditions. The endoglycosidase endo-β-N-acetylglucosaminidase H (Endo H), peptide-N4-(acetyl-β-glucosaminyl) asparagine amidase F (PNGase F), and PNGase A are the most preferred endoglycosidases, N-glycans can be conveniently and non-selectively released from glycoproteins using these enzymes.

Key Technologies

At CD BioGlyco, our glycan enzymatic release services are underpinned by a robust suite of core technologies designed for unparalleled specificity and efficiency. Our expertise lies in the strategic application of a comprehensive panel of highly purified glycosidases and glycoamidases. This includes industry-standard enzymes like PNGase F for the complete and gentle removal of N-linked glycans, as well as an extensive range of exoglycosidases and endoglycosidases optimized for specific glycan linkages and structures. We leverage proprietary enzymatic blends and optimized reaction conditions that are tailored to the unique characteristics of each sample, ensuring maximum glycan release yield with minimal degradation or structural alteration. Our advanced enzymatic platforms are complemented by state-of-the-art analytical instrumentation, allowing for precise monitoring of the release process and immediate preparation for subsequent analytical workflows.

Comprehensive Glycan Release: Tailored Solutions for Every Glycosylation Need

Enzymes are useful for the structural analysis of glycans and polysaccharides and for establishing structure-activity relationships in biological systems. To better characterize glycans on proteins, CD BioGlyco has developed an advanced glycan enzymatic release platform. We provide efficient and accurate release services of N-glycan, fucose, galactose, N-acetylgalactosamine (GalNAc), O-glycosylated protein, core-1 O-glycan, and sialic acid for our clients.

Workflow

Workflow for enzymatic release. (CD BioGlyco)

Publication Data

Journal: Molecules

IF: 4.6

Published: 2023

Results: The authors emphasize the intricacies of protein N-glycosylation and its impact on glycoprotein structure and function, noting that the natural heterogeneity of N-glycans often obscures their precise biological roles. To overcome this, the research details efforts in glycoprotein in vitro N-glycan engineering, specifically through the use of purified recombinant glycoside hydrolases expressed in E. coli. This approach is designed to generate glycoproteins with homogeneous N-glycoforms, thereby enabling clearer elucidation of specific N-glycan functions and facilitating the development of enhanced glycoprotein therapeutics.

Fig.1 Glycoprotein in vitro N-glycan processing. Fig.1 Glycoprotein in vitro N-glycan processing from high-mannose to disialylated biantennary complex-type N-glycans. (Zhang, et al., 2023)

Applications

  • Biopharmaceutical development and quality control: In the biopharmaceutical industry, glycosylation significantly impacts the efficacy, immunogenicity, and stability of therapeutic proteins (e.g., antibodies, enzymes). Enzymatic glycan release is crucial for detailed characterization of glycosylation patterns, enabling comparability studies, biosimilar development, and routine quality control to ensure product safety and potency.
  • Biomarker discovery: Altered glycosylation is a hallmark of numerous diseases, including cancer, inflammatory conditions, and infectious diseases. By enabling precise glycan profiling, enzymatic release facilitates the discovery of novel glycan biomarkers for early disease detection.
  • Vaccine development: Glycans on pathogens often serve as key targets for immune recognition. Understanding the glycosylation of vaccine antigens through enzymatic release and subsequent analysis is vital for designing more effective vaccines that elicit robust and targeted immune responses.
  • Fundamental glycobiology research: Enzymatic glycan release is a foundational technique for elucidating the roles of glycans in various biological processes, including cell signaling, cell adhesion, development, and immunity. It allows for the precise investigation of glycan structure-function relationships.

Advantages

  • Exceptional gentleness: Our enzymatic methods are mild, which minimizes the risk of glycan degradation or structural rearrangements, ensuring that the released glycans accurately reflect their native state.
  • High yield and reproducibility: Through optimized enzyme selection and reaction conditions, we consistently achieve high yields of released glycans. Our standardized protocols and rigorous quality control measures guarantee excellent reproducibility, providing reliable data for your most critical experiments.
  • Compatibility with downstream analysis: Glycans released using our enzymatic methods are perfectly suited for a wide array of downstream analytical techniques, including advanced mass spectrometry (MS), high-performance liquid chromatography (HPLC), hydrophilic interaction liquid chromatography (HILIC), and capillary electrophoresis (CE). The purity and intactness of the released glycans ensure optimal performance in these high-resolution analyses.
  • Customizable solutions: CD BioGlyco offers flexible and customizable enzymatic release strategies tailored to your specific sample type, research goals, and target glycan structures. Our expert team works closely with you to design the most effective workflow.

Frequently Asked Questions

CD BioGlyco focuses on teamwork and uses first-class experimental platforms to provide global biotechnology companies and scientific research institutions with efficient and high-quality services related to glycobiology. Our fast and effective solutions will greatly accelerate the progress of our clients' projects. Please contact us directly for more detailed information if you need scientific assistance.

Associated Services

Beyond our premier glycan enzymatic release services, CD BioGlyco offers a suite of complementary services designed to provide a complete solution for your glycoscience research needs. These offerings are seamlessly integrated with your glycan release projects to achieve your comprehensive analytical goals.

Reference

  1. Zhang, L.; et al. Glycoprotein in vitro N-glycan processing using enzymes expressed in E. coli. Molecules. 2023, 28(6): 2753. (Open Access)
This service is for Research Use Only, not intended for any clinical use.
Quick Links
Resources

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0